Targeting Those Most in Need: Access-Focused Product Partnerships at Novartis

All pharmaceutical companies look to leverage their capabilities to benefit those in the World’s poorest countries. Novartis aims to go beyond corporate philanthropy to create a more sustainable therapy-development model. By marshalling partnerships and its own people, Charlie Bailey leads Novartis teams pursuing development initiatives addressing better-known conditions like malaria, as well as more obscure ones like leishmaniasis. These initiatives can span a decade or more taking therapies through Phase I, II and III clinical trials, then ensuring the infrastructure and skills to offer them in the world’s most remote locations.In this fascinating podcast, Charlie discusses the ideas behind Novartis’s access-focused product partnerships with BTD partner, Nick Palmer. Charlie explains how this new model offers a more sustainable path to addressing suffering in the Third World. Working with NGOs ranging from the Wellcome Trust and the Gates Foundation, to specialised ones like DNDi and MMV, Novartis is charting a course to bring First World therapies to the Third world, AND to push the boundaries of pharmaceutical innovation. He discusses specific examples and experiences to highlight this exciting approach.CLICK HERE to follow us on LinkedInwww.btd.consulting

Om Podcasten

BTD is a specialist consultancy that helps people around the world achieve their long-term acquisition, divestment and alliance goals. BTD looks Beyond the Deal, working in partnership with our clients so that they find and complete deals and alliances that build strategic capabilities; ensure that the deals being considered will be successful post-close; deliver the benefits and objectives of their deals quickly, efficiently and cost-effectively, maintain focus on business as usual during and after the deal process and strengthen their own ability to do deals and alliances consistently well in future. Established in 2001, BTD has worked with over 100 clients around the world including Amadeus, Coca-Cola, E.On, GlaxoSmithKline, and Unilever. With offices in London and Boston and an international team, BTD helps leaders reduce deal time and cost, increase deal value, raise capability and maintain a high-performing businesses through the process. Our bespoke services and collaborative approach delivers confidence in the final outcome while ensuring they stay in full control of the process. From pre-deal to post-close – Go Beyond.